| Berlin Partner. (April 2019). "Special Feature: BIONNALE 2019 in Berlin – the Networking Event for the Life Sciences & Healthcare Industries in the German Capital Region". Berlin. |
2019-04-18 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. |
2019-04-17 |
| Inivata Ltd.. (4/16/19). "Press Release: Inivata, Thermo Fisher Scientific, and Genomics England Successfully Complete First Phase of Study Assessing Plasma Samples and Potential of Liquid Biopsy". |
2019-04-16 |
| MLM Medical Labs GmbH. (4/15/19). "Press Release: Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project to Enable Development and Implementation of Novel Safety Biomarkers". Mönchengladbach. |
2019-04-15 |
| Immunic, Inc.. (4/12/19). "Press Release: Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases". San Diego, CA & Martinsried. |
2019-04-12 |
| Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsvaerd. |
2019-04-12 |
| Uniqure N.V.. (4/8/19). "Press Release: Uniqure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntington’s Disease". Lexington, MA & Amsterdam. |
2019-04-08 |
| Metrion Biosciences Ltd.. (4/8/19). "Press Release: Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer". Cambridge. |
2019-04-08 |
| Novartis AG. (4/4/19). "Press Release: Novartis Updates on the Migraine Collaboration with Amgen". Basel. |
2019-04-04 |
| Nanobiotix S.A.. (4/4/19). "Press Release: Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval". Paris & Cambridge, MA. |
2019-04-04 |
| Bruker Corporation. (4/3/19). "Press Release: Bruker Announces Acquisition of Rave LLC". Billerica, MA. |
2019-04-03 |
| Qiagen N.V.. (4/3/19). "Press Release: Qiagen and LabCorp Launch Collaboration to Provide Day-One Access for Patients to Innovative Companion Diagnostics at the Time of Drug Approvals". Hilden & Germantown, MD. |
2019-04-03 |
| Dyne Therapeutics. (4/3/19). "Press Release: Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases". Cambridge, MA. |
2019-04-03 |
| Roche. (4/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Withdrawal and Refiling of Premerger Notification and Report Form under the HSR Act and Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. |
2019-04-03 |
| ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. |
2019-04-03 |
| Novartis AG. (4/3/19). "Press Release: Sandoz Resubmits Biosimilar Pegfilgrastim Application to US FDA". Holzkirchen. |
2019-04-03 |
| Nanobiotix S.A.. (4/2/19). "Press Release: Combination of First-in-Class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in Vivo Models of Lung Cancer". Paris & Cambridge, MA. |
2019-04-02 |
| Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data". Brisbane, CA. |
2019-04-02 |
| Bayer AG. (4/2/19). "Press Release: Leaps by Bayer and Khloris Join Forces to Develop Induced Pluripotent Stem Cells (iPSCs) as Breakthrough Anti-cancer Vaccines". Leverkusen & South San Francisco, CA. |
2019-04-02 |
| Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy". Brisbane, CA & New York, NY. |
2019-04-02 |
| Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Announces Agreement Securing Access To Large-scale, Commercial-grade Manufacturing Capacity at Brammer Bio". Brisbane, CA. |
2019-04-02 |
| Mologic Ltd.. (4/1/19). "Press Release: Mologic Expands US and UK Operations. Strengthens Team as Part of Continued International Expansion – Bolsters US Presence with the Opening of Subsidiary in Boston, MA". Bedfordshire. |
2019-04-01 |
| Cambridge Innovation Capital plc. (4/1/19). "Press Release: Cambridge Innovation Capital Completes £150 Million New Capital Raise". |
2019-04-01 |
| Novartis AG. (4/1/19). "Press Release: Novartis Adds Clinical and Preclinical Anti-inflammatory Programs to Portfolio with Acquisition of IFM Tre". Basel. |
2019-04-01 |
| Surface Oncology Inc.. (4/1/19). "Press Release: Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer". Cambridge, MA. |
2019-04-01 |
| MorphoSys AG. (4/1/19). "Press Release: Dr. Sarah Fakih Joins MorphoSys as Head of Corporate Communications and Investor Relations". Planegg. |
2019-04-01 |
| Karuna Therapeutics, Inc.. (4/1/19). "Press Release: Karuna Completes $80 Million Series B Financing". Boston, MA. |
2019-04-01 |
| Roche. (4/1/19). "Press Release: Roche’s Ipatasertib in Combination with Tecentriq and Chemotherapy Shows Promising Anti-tumour Activity in Triple-negative Breast Cancer in Early Phase Trial". Basel. |
2019-04-01 |
| Novartis AG. (4/1/19). "Press Release: AveXis Expands World-leading Gene Therapy Manufacturing Capacity with Purchase of Advanced Biologics Therapy Manufacturing Campus in Longmont, Colorado". Basel. |
2019-04-01 |
| Bluebird Bio, Inc.. (3/29/19). "Press Release: Bluebird Bio Receives Positive Opinion from CHMP for Zynteglo (autologous CD34+ cells encoding ßA-T87Q-globin gene) Gene Therapy". Cambridge, MA. |
2019-03-29 |
| Celyad S.A.. (3/28/19). "Press Release: Celyad Appoints Filippo Petti as Chief Executive Officer. Dr Christian Homsy Continues as Non-executive Director and Chair of the Strategy Committee of the Board of Directors". Mont-Saint-Guibert. |
2019-03-28 |
| Blueprint Medicines Corporation. (3/28/19). "Press Release: Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock". Cambridge, MA. |
2019-03-28 |
| Selvita S.A.. (3/28/19). "Press Release: Selvita to Separate Oncology Therapeutics and Contract Research Business Units into Two Global Companies". Krakow. |
2019-03-28 |
| Selvita S.A.. (3/28/19). "Press Release: Selvita Posts 67 Percent Increase in Operating Profit for Services Division, Innovative Research Division Reaches Inflection Point as SEL120 Enters Clinical Development". Krakow. |
2019-03-28 |
| ArcherDX, Inc.. (3/28/19). "Press Release: ArcherDX Announces Collaboration with University College London to Investigate the Novel Use of Cell-Free Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients". Boulder, CO. |
2019-03-28 |
| Qiagen N.V.. (3/28/19). "Press Release: Qiagen Launches Novel Liquid Biopsy Solutions and NGS Panels with Seamlessly Integrated Bioinformatics to Support Advances in Cancer Research". Germantown, MD & Hilden. |
2019-03-28 |
| Inivata Ltd.. (3/28/19). "Press Release: Inivata Completes $52.6m (£39.8m) Series B Funding Round". Research Triangle Park, NC & Cambridge. |
2019-03-28 |
| Indivumed GmbH. (3/28/19). "Press Release: Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services". Hamburg & Westminster, CO. |
2019-03-28 |
| Celyad S.A.. (3/28/19). "Press Release: Celyad Reports Business Update and Full Year 2018 Financial and Operating Results". Mont-Saint-Guibert. |
2019-03-28 |
| Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel. |
2019-03-28 |
| Genfit S.A.. (3/27/19). "Press Release: Genfit Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market". Lille & Cambridge, MA. |
2019-03-27 |
| Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. |
2019-03-27 |
| Cerenis Therapeutics S.A.. (3/27/19). "Press Release: Cerenis Therapeutics and H4Orphan Pharma Enter into Exclusive Negotiations to Consider a Strategic Merger". Toulouse. |
2019-03-27 |
| MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY. |
2019-03-26 |
| Evaluate Ltd.. (3/26/19). "Press Release: Evaluate Ltd. Appoints Deborah Kobewka as Chief Executive Officer". London, Boston, MA & Tokyo. |
2019-03-26 |
| Evotec AG. (3/26/19). "Press Release: Evotec and The Mark Foundation for Cancer Research Announce Strategic Collaboration in Immuno-oncology". Hamburg. |
2019-03-26 |
| PharmaMar S.A.. (3/25/19). "Press Release: PharmaMar Announces Positive Results in Its Lurbinectedin Monotherapy Trial for Small Cell Lung Cancer". Madrid. |
2019-03-25 |
| Aimmune Therapeutics, Inc.. (3/25/19). "Press Release: European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint. Company Intends to Submit European MAA in Mid-2019". Brisbane, CA. |
2019-03-25 |
| Thermo Fisher Scientific Inc.. (3/24/19). "Press Release: Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing". Waltham, MA & Cambridge, MA. |
2019-03-24 |
| Akoya Biosciences, Inc.. (3/22/19). "Press Release: Akoya Biosciences Launches Comprehensive Solution for High-Parameter Tissue Analysis". Menlo Park, CA. |
2019-03-22 |
| Verona Pharma plc. (3/21/19). "Press Release: Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director". London. |
2019-03-21 |
| Orchard Therapeutics Ltd.. (3/21/19). "Press Release: Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights". Boston, MA & London. |
2019-03-21 |
| Sherlock Biosciences Inc.. (3/21/19). "Press Release: Sherlock Biosciences Launches to Provide Better, Faster and More Affordable Diagnostic Testing Worldwide Through Engineering Biology". Cambridge, MA. |
2019-03-21 |
| MichBio. (3/20/19). "Press Release: MichBio Announces 7th Annual »Michigan Biosciences Day at the Capitol,« Seeks Participants". Ann Arbor, MI & Lansing, MI. |
2019-03-20 |
| Vivet Therapeutics S.A.S.. (3/20/19). "Press Release: Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics". Paris & New York, NY. |
2019-03-20 |
| 4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. |
2019-03-20 |
| Atlatl Innovation Cluster. (3/20/19). "Press Release: Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai". Shanghai. |
2019-03-20 |
| NeoPhore Ltd.. (3/20/19). "Press Release: NeoPhore Appoints Dr John Haurum as Non-Executive Director. Former F-star CEO Joins the Board of Directors". |
2019-03-20 |
| Roche. (3/19/19). "Press Release: FDA Approves Roche’s Tecentriq in Combination with Chemotherapy for the Initial Treatment of Adults with Extensive-stage Small Cell Lung Cancer". Basel. |
2019-03-19 |
| Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. |
2019-03-19 |
| Affimed N.V.. (3/19/19). "Press Release: Affimed Announces Milestone Payment from Genentech and ROCK Platform Presentation at Innate Killer Summit 2019, Further Highlighting Leadership in Innate Immunity". Heidelberg. |
2019-03-19 |
| Karuna Therapeutics, Inc.. (3/18/19). "Press Release: Karuna Announces $68 Million Series B Financing". Boston, MA. |
2019-03-18 |
| Aimmune Therapeutics, Inc.. (3/18/19). "Press Release: U.S. FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut Allergy". Brisbane, CA. |
2019-03-18 |
| Celyad S.A.. (3/18/19). "Press Release: Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates". Mont-Saint-Guibert. |
2019-03-18 |
| Orchard Therapeutics Ltd.. (3/18/19). "Press Release: Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer". Boston, MA & London. |
2019-03-18 |
| SilverSky LifeSciences GmbH. (3/18/19). "Press Release: DxPx – The First International Diagnostics Partnering Conference". Düsseldorf. |
2019-03-18 |
| Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. |
2019-03-14 |
| Bruker Corporation. (3/14/19). "Press Release: Bruker Announces Acquisition of Scientific Software Provider Arxspan". Billerica, MA. |
2019-03-14 |
| Oxford BioMedica plc. (3/14/19). "Press Release: Oxford Biomedica plc Preliminary Results for the Year Ended 31 December 2018". Oxford. |
2019-03-14 |
| AstraZeneca plc. (3/14/19). "Press Release: AstraZeneca Showcases Next-generation Oncology Pipeline Addressing Unmet Patient Needs at AACR Annual Meeting". |
2019-03-14 |
| Mammoth Biosciences, Inc.. (3/14/19). "Press Release: Mammoth Biosciences Secures Exclusive License to Commercialize Novel CRISPR Protein". San Francisco, CA. |
2019-03-14 |
| Argenx SE. (3/14/19). "Press Release: Argenx to Receive First Clinical Milestone Payment for Product Candidate Developed". Breda & Ghent. |
2019-03-14 |
| Genfit S.A.. (3/14/19). "Press Release: Genfit Announces Launch of Proposed Global Offering and Nasdaq Listing". Lille & Cambridge, MA. |
2019-03-14 |
| Cambrex Corporation. (3/14/19). "Press Release: Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan". East Rutherford, NJ. |
2019-03-14 |
| CARB-X. (3/14/19). "Press Release: Germany Joins CARB-X Partnership in the Fight against Deadly Drug-resistant Superbugs". Berlin. |
2019-03-14 |
| Ovation.io. (3/14/19). "Press Release: Ovation.io Secures $5 Million Series A Funding to Accelerate Growth of Cloud Based Laboratory Information Systems for Clinical Informatics". Boston, MA & Indianapolis, IN. |
2019-03-14 |
| MorphoSys AG. (3/13/19). "Press Release: MorphoSys Presents Results for Fiscal Year 2018". Planegg. |
2019-03-13 |
| Deerfield Management Company L.P.. (3/13/19). "Press Release: Harvard and Deerfield Establish Lab1636, a Major Translational Research Alliance". Cambridge, MA. |
2019-03-13 |
| MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan. |
2019-03-13 |
| iOnctura S.A.. (3/12/19). "Press Release: iOnctura Bolsters Management Team with Senior Appointments. Michael Lahn Appointed Chief Medical Officer – Zoë Johnson Appointed Chief Scientific Officer". Geneva. |
2019-03-12 |
| Osage University Partners. (3/12/19). "Press Release: Osage University Partners Closes Oversubscribed $273 Million Third Venture Fund for University Startups". Bala Cynwyd, PA. |
2019-03-12 |
| Biogen Inc.. (3/12/19). "Press Release: Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm". Cambridge. |
2019-03-12 |
| Oxford BioMedica plc. (3/12/19). "Press Release: Oxford Biomedica Announces R&D Collaboration with Microsoft to Improve Gene and Cell Therapy Manufacturing Using the Intelligent Cloud and Machine Learning". Oxford. |
2019-03-12 |
| ERS Genomics Ltd.. (3/12/19). "Press Release: ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent including Uses of CRISPR »in a Cell«". Dublin. |
2019-03-12 |
| Olink Proteomics. (3/12/19). "Press Release: Summa Equity Acquires Olink Proteomics". |
2019-03-12 |
| Seres Therapeutics, Inc.. (3/11/19). "Press Release: Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca". Cambridge, MA. |
2019-03-11 |
| InventisBio Inc.. (3/11/19). "Press Release: Clinical Stage Biotech Company InventisBio Inc. Closes $70 Million USD Series C Financing". Shanghai. |
2019-03-11 |
| Tecan Group Ltd.. (3/11/19). "Press Release: Tecan Reports Strong Second Half and a Very Successful Fiscal Year 2018". Männedorf. |
2019-03-11 |
| Tecan Group Ltd.. (3/8/19). "Press Release: Qiagen and Tecan Announce Collaboration to Streamline Preanalytical Processing of QuantiFERON-TB Gold Plus". Männedorf, Germantown, MD & Hilden. |
2019-03-08 |
| Celyad S.A.. (3/8/19). "Press Release: Celyad Appoints Anne Moore as Vice President Corporate Strategy". Mont-Saint-Guibert. |
2019-03-08 |
| Allogene Therapeutics, Inc.. (3/8/19). "Press Release: Allogene Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results". South San Francisco, CA. |
2019-03-08 |
| Boehringer Ingelheim. (3/7/19). "Press Release: Novel Antibody Shows Potential to Transform Treatment of Rare Form of Psoriasis". Ingelheim. |
2019-03-07 |
| Gilde Healthcare Partners. (3/7/19). "Press Release: Gilde Healthcare Raises €200 Million for New Private Equity Fund.
Targeting Lower Mid-market Healthcare Investments in the Benelux and DACH Regions". Utrecht & Frankfurt a. M.. |
2019-03-07 |
| SOM Biotech S.L.. (3/7/19). "Press Release: SOM Biotech Closes a Financing Round of 7m Euros". Barcelona. |
2019-03-07 |
| Moderna, Inc.. (3/6/19). "Press Release: Moderna Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights Recent Pipeline Progress". Cambridge, MA. |
2019-03-06 |
| Seres Therapeutics, Inc.. (3/6/19). "Press Release: Seres Therapeutics Reports Fourth Quarter and Full Year Financial Results and Provides Operational Updates". Cambridge, MA. |
2019-03-06 |
| Eurofins Scientific. (3/5/19). "Press Release: Eurofins Delivers Solid FY 2018 Results with Revenues of EUR 3,781m (+27% yoy) and Adjusted EBITDA of EUR 720m (19.0% of revenues), in Line with Its Recently Upgraded Objectives". |
2019-03-05 |
| Karuna Pharmaceuticals, Inc.. (3/5/19). "Press Release: Karuna Strengthens Senior Leadership Team with Appointment of Chief Financial Officer. Karuna Appoints Troy Ignelzi as Chief Financial Officer". Boston, MA. |
2019-03-05 |
| Erasca, Inc.. (3/5/19). "Press Release: Erasca Announces Series A Extension, Bringing Total Round to $64 Million". San Diego, CA. |
2019-03-05 |
| Merck KGaA. (3/5/19). "Press Release: Open Letter to Versum Shareholders from Merck". Darmstadt. |
2019-03-05 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo-2018.jpg){kind=logo}
Date![Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px](/banner/iito-20150529-600-080-lsg-life-sciences-germany-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)